Shopping Cart
- Remove All
- Your shopping cart is currently empty
LSD1-IN-36, an effective LSD1 inhibitor with an IC50 value of 0.8 nM, induces cell apoptosis and arrests the cell cycle. This compound also exhibits antitumor activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | LSD1-IN-36, an effective LSD1 inhibitor with an IC50 value of 0.8 nM, induces cell apoptosis and arrests the cell cycle. This compound also exhibits antitumor activity. |
Targets&IC50 | LSD1:0.8 nM |
In vitro | LSD1-IN-36 (compound 10e) exhibits significant inhibitory effects in various human tumor cell lines, showing strong activity against HCT116, MCF-7, A549, and MDA-MB-231 cells with IC50 values of 0.1 μM, 0.1 μM, 0.3 μM, and 0.8 μM, respectively. At concentrations ranging from 0.125 to 0.5 μM over 72 hours, LSD1-IN-36 significantly inhibits clonal formation in HCT116 cells, induces apoptosis, arrests the cell cycle, and increases the expression of H3K9me2, H3K9me1, H3K4me2, and H3K4me1 in HCT116 cells. |
In vivo | Administered intraperitoneally at a dose of 60 mg/kg daily for three weeks, LSD1-IN-36 (compound 10e) demonstrated a significant tumor suppression rate in vivo. |
Molecular Weight | 459.52 |
Formula | C22H25N3O6S |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.